Question 1

What are the main differences between AVT32-DRL_PB and Keytruda?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma clinical trial (NCT07475572). Contact the study team or your healthcare provider for specific answers.

Question 2

How will I know if I am eligible for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma clinical trial (NCT07475572). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of each treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma clinical trial (NCT07475572). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma clinical trial (NCT07475572). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the treatment cycles?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma clinical trial (NCT07475572). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma clinical trial (NCT07475572). Contact the study team or your healthcare provider for specific answers.

What this study is about